Form 4 for AMGN Amgen
Accepted 2026-08-13 19:05:29 ET · period of report 2026-08-11 · accession 0000318154-26-000137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-13 19:05 | 2026-08-11+ | AMGN | Khosla Rachna | SVP, Business Development | S - Sale+OE | $414.05 | -3,252 | 6,404 | -34% | -$1.35M |
| D | 2026-08-13 19:05 | 2026-08-13 | AMGN | Khosla Rachna | SVP, Business Development | M - OptEx | $162.60 | +1,252 | 7,656 | +20% | +$203.6K |
| D | 2026-08-13 19:05 | 2026-08-13 | AMGN | Khosla Rachna | SVP, Business Development | M - OptEx | $0.00 | -1,252 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-11 | S | D | 2,000 | $412.57 | 6,404 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-13 | M | A | 1,252 | $162.60 | 7,656 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-13 | S | D | 1,252 | $416.43 | 6,404 | D | — | — | (F1) Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. (F2) These shares include 69 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| 4 | Derivative | Nqso (Right to Buy) | 2026-08-13 | M | D | 1,252 | $0.00 | 0 | D | $162.60 · 2019-05-01 to 2027-05-01 | 1,252 Common Stock |